(CNS) Cohen & Steers - Ratings and Ratios
Mutual Funds, Hedge Funds, Separate Accounts
CNS EPS (Earnings per Share)
CNS Revenue
Description: CNS Cohen & Steers
Cohen & Steers Inc (NYSE:CNS) is a global investment manager specializing in real assets and alternative income, operating through its subsidiaries to provide services to institutional investors, including pension funds, endowments, and foundations. The company manages a diverse range of portfolios, including equity, fixed income, multi-asset, and commodity investments, and launches mutual funds and hedge funds.
The firms investment strategy focuses on public equity, fixed income, and commodity markets worldwide, with a particular emphasis on the real estate sector, infrastructure, and natural energy resources. It also invests in preferred securities for its fixed income investments. With a strong track record since its founding in 1986, Cohen & Steers has established itself as a leading player in the asset management industry, with a presence in New York and a global reach.
Analyzing the available data, we can observe that the stock has experienced a decline in recent times, with the last price at $76.33, below its 20-day SMA of $78.67 and significantly lower than its 52-week high of $105.03. The current price is near its 50-day SMA, indicating a potential support level. However, the long-term trend remains bearish, as the stock is still far from its 200-day SMA of $87.28.
Using the available technical and fundamental data, a forecast can be made. Given the current P/E ratio of 25.45 and forward P/E of 25.13, the stock appears to be fairly valued. The RoE of 31.83% indicates a strong profitability profile. Considering the ATR of 1.84, representing a 2.41% daily volatility, and the current price near the 52-week low, a potential buying opportunity may arise if the stock demonstrates a strong reversal signal. A potential price target could be the 50-day SMA, and subsequently, the 200-day SMA, if the overall market sentiment improves and the firm continues to demonstrate strong financial performance.
Based on the analysis, it is essential to monitor the stocks price action and wait for a clear reversal signal before making any investment decisions. A thorough examination of the companys financials, management team, and industry trends is also necessary to determine the stocks potential for long-term growth.
Additional Sources for CNS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
CNS Stock Overview
Market Cap in USD | 3,935m |
Sector | Financial Services |
Industry | Asset Management |
GiC Sub-Industry | Asset Management & Custody Banks |
IPO / Inception | 2004-08-13 |
CNS Stock Ratings
Growth Rating | 15.6 |
Fundamental | 34.5 |
Dividend Rating | 63.6 |
Rel. Strength | -14.4 |
Analysts | 4 of 5 |
Fair Price Momentum | 71.90 USD |
Fair Price DCF | 22.48 USD |
CNS Dividends
Dividend Yield 12m | 2.97% |
Yield on Cost 5y | 4.16% |
Annual Growth 5y | 8.63% |
Payout Consistency | 84.0% |
Payout Ratio | 81.2% |
CNS Growth Ratios
Growth Correlation 3m | 32.3% |
Growth Correlation 12m | -43.4% |
Growth Correlation 5y | 46.4% |
CAGR 5y | 6.04% |
CAGR/Max DD 5y | 0.13 |
Sharpe Ratio 12m | 0.14 |
Alpha | 0.43 |
Beta | 0.615 |
Volatility | 30.77% |
Current Volume | 123.9k |
Average Volume 20d | 156.2k |
As of July 05, 2025, the stock is trading at USD 78.01 with a total of 123,900 shares traded.
Over the past week, the price has changed by -0.13%, over one month by +3.00%, over three months by +3.80% and over the past year by +11.22%.
Neither. Based on ValueRay´s Fundamental Analyses, Cohen & Steers is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 34.48 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CNS is around 71.90 USD . This means that CNS is currently overvalued and has a potential downside of -7.83%.
Cohen & Steers has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CNS.
- Strong Buy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, CNS Cohen & Steers will be worth about 81.6 in July 2026. The stock is currently trading at 78.01. This means that the stock has a potential upside of +4.63%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 82.5 | 5.8% |
Analysts Target Price | 82.5 | 5.8% |
ValueRay Target Price | 81.6 | 4.6% |